SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001437749-20-012350
Filing Date
2020-06-03
Accepted
2020-06-03 16:43:48
Documents
7

Document Format Files

Seq Description Document Type Size
1 FORM S-1 navb20200602_s1.htm S-1 435036
2 EXHIBIT 5.1 ex_189014.htm EX-5.1 9662
3 EXHIBIT 23.1 ex_188987.htm EX-23.1 2920
4 altlogo5_1.jpg GRAPHIC 567281
5 footer5_1.jpg GRAPHIC 576334
6 logo5_1.jpg GRAPHIC 575477
7 navlogo01.jpg GRAPHIC 5578
  Complete submission text file 0001437749-20-012350.txt   2811212
Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017
Business Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-238911 | Film No.: 20940559
SIC: 2835 In Vitro & In Vivo Diagnostic Substances